Patrick Dolezal
Stock Analyst at LifeSci Capital
(2.61)
# 2,079
Out of 5,124 analysts
3
Total ratings
66.67%
Success rate
23.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Dolezal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGNE Neurogene | Initiates: Outperform | $50 | $17.20 | +190.78% | 1 | Jan 26, 2026 | |
| KOD Kodiak Sciences | Initiates: Outperform | $40 | $23.04 | +73.61% | 1 | Oct 23, 2025 | |
| AVDL Avadel Pharmaceuticals | Maintains: Outperform | $17 → $26 | $21.69 | +19.87% | 1 | May 2, 2023 |
Neurogene
Jan 26, 2026
Initiates: Outperform
Price Target: $50
Current: $17.20
Upside: +190.78%
Kodiak Sciences
Oct 23, 2025
Initiates: Outperform
Price Target: $40
Current: $23.04
Upside: +73.61%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Outperform
Price Target: $17 → $26
Current: $21.69
Upside: +19.87%